Adams Named Chair of Dermatology
Brian Adams, MD, MPH, has been approved by the UC Board of Trustees as the permanent chair of the UC Department of Dermatology. He also will hold the Drs. Diya F. Mutasim & Hugh M. Gloster Jr. & Harry L. Claassen Endowed Chair of Dermatology. Adams has served as interim chair of the department since Jan. 1, 2013.
He joined the faculty of the department in 1999, after completing his internship and residency at the UC College of Medicine.
A board-certified dermatologist, he also serves as director of dermatology for the Cincinnati Department of Veterans Affairs Medical Center and leads the UC dermatology departments sports dermatology clinic and its residency program. Additionally, Dr. Adams is a member of the Athletic Training Program at the School of Human Services within UC's College of Education, Criminal Justice and Human Services.
He is the official dermatologist for the Womens Tennis Association and a member of several national committees related to sports medicine and dermatology. His ongoing research focuses on skin cancer prevention among athletes. Adams authored the 2006 book
and has authored or co-authored more than 135 manuscripts, abstracts and book chapters (including the chapter on sports dermatology for the International Olympic Committees medical textbook).
He also serves as an assistant coach for the Archbishop Moeller High School varsity cross country team.
Adams will serve from 2015 to 2019 as the chairman of the American Academy of Dermatology Sports Committee and is a member of the American College of Sports Medicines Combative Sports Interest Group.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.